Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion type Assertion NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_head.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion description "[Therefore, orexin receptor controlling hypothalamic insulin/leptin actions may be a new target for possible future treatment of hyperglycaemia in patients with type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_provenance.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion evidence source_evidence_literature NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_provenance.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion SIO_000772 19489767 NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_provenance.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion wasDerivedFrom befree-2016 NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_provenance.
- NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_assertion wasGeneratedBy ECO_0000203 NP742565.RApqy0VYcvLZ680G-bZvgNswxLnKUbvl1YxqHRcer6z9U130_provenance.